Over the past 30 years, the Pharmaceutical supply chain has expanded to cover the globe. An eco system that spans the United States, China, France and beyond has been developed to produce drugs and the methods and ingredients can often be difficult to monitor As a result there have been many recalls of drugs including heparin injections from Baxter International according to Life Science Leader. Even with road bumps like those, the industry has increased imports by 50% leading to a $81.5 billion market. The challenge facing this particular industry is quality. How can the industry maintain the high standards that are required for medications taken by the general population? While a challenge, author Karl Schmieder believes it can be done. Through new technology that has been developed including cloud computing and on demand technology, suppliers across the supply chain can work together to assure high standards and quality.
At the upcoming Biopharmaceutical Development & Production Week taking place February 25-March 1, 2013, Jason Brady, Head of Business Development, Conjugates and Cytotoxics, will be on hand to present "Lonza Custom Manufacturing Sourcing ADC Development and Manufacturing Services for a More Efficient Supply Chain" to look at the process of the supply chain in more depth. He will be presenting as a part of the Alliance Integration and Supply Chain Management track. For more information on BDP Week, download the agenda.
How important is is to develop a transparent supply chain for Pharma companies? Is it something that's possible?
|
Share this article with your social network, just click below to share now!
|
|
|
No comments :
Post a Comment